[(How) can progression of chronic kidney diseases be retarded?]
(How) can progression of chronic kidney diseases be retarded? Abstract. A variety of etiologically diverse chronic kidney diseases (CKD) may not only progress to end stage renal disease, but also increase cardiovascular morbidity and overall mortality. Once a critical mass of renal tissue has been irreversibly scarred, maladaptive mechanisms lead to progressive loss of the remaining kidney tissue, independent of the initial mechanism causing kidney injury. Medical treatments that retard the progression of CKD by directly and specifically inhibiting profibrotic processes unfortunately do not yet exist. The best established treatment intervention to retard CKD progression consists of ACE inhibitors and angiotensin receptor blockers in patients with relevant proteinuria. Recent data support alkali supplementation. Furthermore, moderation of salt consumption and smoking cessation are probably beneficial. Finally, "second hits" leading to acute kidney injury episodes should be avoided. Apart from these unspecific measures, it is essential to identify renal diseases amenable to cause-specific treatments. The possibilities as well as the limits of treatment options to retard progression of CKD will be critically discussed in this article.